EMBRACA Trial in HER2 Metastatic Breast Cancer

EMBRACA Trial in HER2 Metastatic Breast Cancer

User Photo
obr

1 year
191 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Neelima Denduluri MD, Associate Professor, US Oncology Research, Virginia Cancer Specialists shares the results of the phase III EMBARCA trial that compares the efficacy and safety of talazoparib (TALA) to PCT (capecitabine, eribulin, gemcitabine, vinorelbine) in HER2-metastatic breast cancer patients.
Up Next Autoplay
>